| Authors: |
Garrett A; Terasaki Institute for Biomedical Innovation, Los Angeles, CA 90024, USA; Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Darzi N; Department of Molecular Cell Biology, Weizmann Institute of Science, 7610001 Rehovot, Israel., Deshmukh A; Department of Electrical and Computer Engineering, Duke University, Durham, NC 27708, USA; Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI 53706, USA., Rosenfeld N; Department of Molecular Cell Biology, Weizmann Institute of Science, 7610001 Rehovot, Israel., Goldman O; Department of Molecular Cell Biology, Weizmann Institute of Science, 7610001 Rehovot, Israel., Adler L; Department of Molecular Cell Biology, Weizmann Institute of Science, 7610001 Rehovot, Israel., Bab-Dinitz E; Department of Molecular Cell Biology, Weizmann Institute of Science, 7610001 Rehovot, Israel., Singer O; Department of Life Science Core Facilities, Weizmann Institute of Science, 7610001 Rehovot, Israel., Hassani Najafabadi A; Terasaki Institute for Biomedical Innovation, Los Angeles, CA 90024, USA., Wong CW; Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bose S; Department of Internal Medicine, University of Chicago, Chicago, IL 60637, USA., Randon PM; Medical Scientist Training Program, Vanderbilt University Medical School, Nashville, TN 37235, USA., Bustamante F; Terasaki Institute for Biomedical Innovation, Los Angeles, CA 90024, USA., Larios R; Terasaki Institute for Biomedical Innovation, Los Angeles, CA 90024, USA., Brandis A; Department of Life Science Core Facilities, Weizmann Institute of Science, 7610001 Rehovot, Israel., Mehlman T; Department of Life Science Core Facilities, Weizmann Institute of Science, 7610001 Rehovot, Israel., Smaglo B; Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chang P; Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Oliva J; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Haymaker C; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nagawekar L; Clinical Engineering and Applied Research, Abbot Laboratories, Sylmar, CA 91342, USA., Wu SR; Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA., Huang Y; Alfred E. Mann Department of Biomedical Engineering, University of Southern California, Los Angeles, CA 90089, USA., Shen A; Terasaki Institute for Biomedical Innovation, Los Angeles, CA 90024, USA., Vora A; Terasaki Institute for Biomedical Innovation, Los Angeles, CA 90024, USA., Padilla JF; Terasaki Institute for Biomedical Innovation, Los Angeles, CA 90024, USA., Pfeffer A; Terasaki Institute for Biomedical Innovation, Los Angeles, CA 90024, USA., Sutherland G; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA., Starr M; Department of Medicine, Duke University, Durham, NC 27708, USA., Zimmers T; Department of Cell, Developmental and Cancer Biology, School of Medicine, Oregon Health & Science University, Portland, OR 97239, USA., Zhu Y; Terasaki Institute for Biomedical Innovation, Los Angeles, CA 90024, USA., Morizio J; Department of Electrical and Computer Engineering, Duke University, Durham, NC 27708, USA., Erez A; Department of Molecular Cell Biology, Weizmann Institute of Science, 7610001 Rehovot, Israel. Electronic address: ayelet.erez@weizmann.ac.il., Shen X; Terasaki Institute for Biomedical Innovation, Los Angeles, CA 90024, USA; Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: xshen3@mdanderson.org. |
